1Ashwood P,Harvey R,Verjee T.Functional interactions between mucosal IL-l,IL-lra and TGF-beta 1 in ulcer ative colitis[ J ].Inflamm Res, 2004,53 (2) : 53.
2McAlindon ME,Hawkey CJ,Mahida YR.Expression ofin-terleukin 1 beta and interleukin 1 beta converting en- zymeby intestinal macrophages in health and inflammatory bowel disease[J].Gut,1998,42:214-219.
3ho H,Takazoe M,Fukuda Y,et alA pilot randomized trialof a human anti-interleukin-6 receptor monoclonal antibodyin active Crohn's disease [ J ].Gastroenterology, 2004,126 (4) : 989-996.
6Nielsen OH,Kirman I,Rudiger N,et al upregulation of IL-12 and IL-17 in active IBD[J].Gastroenteral,2003,38 (2):180-185.
7Mangan PR,Harrington LE, O'Quinn DB,Helms WS,et al. Transforming growth factor-beta induces development of the T(H)17 lineage[J].Nature,2006,441:231-234.
8Paradowska A,Masliniski W,Grzybowska-Kowalczyk A,et al. The function of interleukin 17 in the pathogenesis of rheumatoid arthritis[J].Arch Immunol Ther Exp (Warsz), 2007,55 : 329-334.
9Cho ML,Kang JW,Moon YM,et aI.STAT3 and NF-kap- paB signalpathway is required for IL-23-mediated IL-17 produetionin spontaneous arthritis animal model IL-1 re- eeptorantagonist -deficient mice [ J ].lmmunol, 2006,176 : 5652-5661.
10Langrish CL,Chen Y,Blumenschein WM,et al.IL-23 drives a pathogenic T cell population that induces auto immune inflammation[J].Exp Meal,2005,201: 233-240.
3Ikeda Y, Akbar SM, Matsui H, Onji M. Antigen-presenting dendritic cells in ulcerative colitis. J Gastroenterol 2002;37(Suppl 14):53-55.
4Bamias G, Marini M, Moskaluk CA, Odashima M, Ross WG,Rivera-Nieves J, Cominelli F. Down-regulation of intestinal lymphocyte activation and Thl cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol 2002;169:5308-5314.
5Sawa Y, Oshitani N, Adachi K, Higuchi K, Matsumoto T,Arakawa T. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease.Int J Mol Med 2003;11:175-179.
6Lakatos L. Immunology of inflammatory bowel diseases. Acta Physiol Hung 2000;87:355-372.
7Hata K, Andoh A, Sato H, Araki Y, Tanaka M, Tsujikawa T,Fujiyama Y, Bamba T. Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand J Gastroenterol 2001;36:1185-1192.
8Sun FF, Lai PS, Yue G, Yin K, Nagele RG, Tong DM, Krzesicki RF, Chin JE, Wong PY. Pattern of cytokine and adhesion molecule mRNA in hapten- induced relapsing colon inflammation in the rat. Inflammation 2001;25:33-45.
9Sandborn WJ. Strategies for targeting tumour necrosis factor in IBD. Best Pract Res Clin Gastroenterol 2003;17:105-117.
10Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR. Efficacy of antitumor necrosis factor therapy in patients with ulcerative colitis.Am J Gastroenterol 2002;97:2577-2584.
